METHDILAZINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methdilazine and what is the scope of patent protection?
Methdilazine
is the generic ingredient in two branded drugs marketed by Westwood Squibb and Alpharma Us Pharms, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for methdilazine.
Summary for METHDILAZINE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Drug Master File Entries: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Patent Applications: | 3,980 |
| DailyMed Link: | METHDILAZINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METHDILAZINE
US Patents and Regulatory Information for METHDILAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Westwood Squibb | TACARYL | methdilazine | TABLET, CHEWABLE;ORAL | 011950-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Westwood Squibb | TACARYL | methdilazine hydrochloride | TABLET;ORAL | 011950-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Westwood Squibb | TACARYL | methdilazine hydrochloride | SYRUP;ORAL | 011950-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alpharma Us Pharms | METHDILAZINE HYDROCHLORIDE | methdilazine hydrochloride | SYRUP;ORAL | 087122-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
